West Pharmaceutical Services, Inc., commonly referred to as West, is a leading provider of innovative solutions for injectable drug delivery and containment. Headquartered in the United States, West operates extensively across major regions, including Europe and Asia, serving a global clientele in the pharmaceutical and biotechnology industries. Founded in 1923, the company has achieved significant milestones, including advancements in drug delivery systems and the development of high-quality packaging solutions. West's core offerings include a range of primary packaging components, delivery systems, and contract manufacturing services, all designed to enhance the safety and efficacy of medications. What sets West apart is its commitment to quality and innovation, ensuring that its products meet the stringent demands of the healthcare sector. With a strong market position and a reputation for excellence, West continues to be a trusted partner for pharmaceutical companies worldwide.
How does West Pharmaceutical Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
West Pharmaceutical Services's score of 48 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, West Pharmaceutical Services, headquartered in the US, reported total carbon emissions of approximately 97,903,000 kg CO2e. This figure includes 31,311,000 kg CO2e from Scope 1 emissions and 66,576,000 kg CO2e from Scope 2 emissions. In comparison, the previous year, 2023, the company recorded total emissions of about 104,190,000 kg CO2e, with Scope 1 emissions at 30,828,000 kg CO2e and Scope 2 emissions at 73,173,000 kg CO2e. West Pharmaceutical Services has set ambitious climate commitments, aiming to reduce absolute emissions by 40% across all scopes by 2030. This target includes a specific focus on reducing Scope 1 and Scope 2 emissions by 10% from 2019 to 2023, which they have been tracking. The company is also committed to achieving 50% renewable electricity and improving energy efficiency by 3% year-over-year. The emissions data reflects a commitment to transparency and accountability in their environmental impact, aligning with industry standards for climate action. West Pharmaceutical Services has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement.
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 28,699,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 118,243,000 | - | 000,000,000 | - | - | - | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
West Pharmaceutical Services has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about West Pharmaceutical Services's sustainability data and climate commitments